Alternative Female Kangaroo Care: an intervention to reduce pain response in preterm neonates (28 - 36 weeks)

ISRCTN ISRCTN71855294
DOI https://doi.org/10.1186/ISRCTN71855294
Secondary identifying numbers A09-B33-06A
Submission date
19/07/2007
Registration date
03/10/2007
Last edited
19/07/2021
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Signs and Symptoms
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Celeste Johnston
Scientific

3506 University, room 226
Montreal
H3A 2A7
Canada

Study information

Study designThis study is a test of non-inferiority or alternate mother KC versus maternal KC. It is a crossover design where neonates served as their own control.
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific titleAlternative Female Kangaroo Care: an intervention to reduce pain response in preterm neonates (28 - 36 weeks)
Study acronymAFKC
Study objectivesPrimary hypothesis:
There will be no difference in pain response and time to recovery from heel lance in 28 - 36 weeks gestational age Neonatal Intensive Care Unit (NICU) preterm neonates when they are engaged in maternal Kangaroo Care (KC) compared to when they are engaged in Alternative Female Kangaroo Care (AFKC).
Ethics approval(s)Study approved by McGill University Institutional Review Board (IRB) on 11th September 2006 (ref: A09-B33-06A).
Health condition(s) or problem(s) studiedPain response
InterventionAfter obtained informed consent from the mother and the alternative female, the neonate will be randomised to:
1. Control group: mother first and alternative female second, or
2. Treatment group: alternative female first and mother second

Kangaroo Care involves placing a diaper-clad neonate at an angle of sixty degrees between the breasts providing maximal skin-to-skin contact between the infant and the caregiver. The neonate is placed in KC for 15 minutes before the painful procedure (heelstick) performed by a hospital technician assigned to the study. The alternative female will wear a mask if she did not visit her general practioner for good health within two days of the treatment condition.

All alternate females will wash their chest with an non-scented soap common to the NICU and will respect the hand washing procedures recommended by the NICU. The heel-lance procedure is relatively standardised across staff and timing and is an aspect of routine care for hospitalised preterm neonates. Each neonate will have two KC sessions filmed; one with the mother and one with the alternative female. The measures will be taken for the entire heel-lance procedure (one minute baseline, one minute warming of the neonate's foot, stick, extraction of the blood and return to baseline).

Second sponsor:
Canadian Nurses Foundation (Canadian Nurses Fondation [CNF])
50 Driveway
Ottawa, Ontario
K2P 1E2
Canada
Intervention typeOther
Primary outcome measure1. Pain measured with Premature Infant Pain Profile (PIPP)
2. Facial actions of the PIPP scored according to Neonatal Facial Coding System (NFCS)
Secondary outcome measuresTime for return to physiological baseline measured as the preterm neonate's return to baseline Heart Rate (HR) after the heel lance procedure procured via an oximeter placed on the unaffected foot of the neonate.
Overall study start date11/09/2006
Completion date11/09/2008

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexFemale
Target number of participantsN = 64, power = 0.8, alpha = 0.05 using the PIPP with a difference of 1 point of the PIPP scale.
Total final enrolment18
Key inclusion criteria1. Born between 28 0/7 weeks and 36 6/7 gestational age
2. Obtained consent
3. Receiving at least two heel lances prior to discharge
4. Within 10 days of hospitalisation
5. Neonate has to be stable according to the Neonatal Intensive Care Unit criteria
6. Alternate female had to be healthy and older than 18 years old
Key exclusion criteriaDoes not comply with the inclusion criteria.
Date of first enrolment11/09/2006
Date of final enrolment11/09/2008

Locations

Countries of recruitment

  • Canada

Study participating centre

3506 University, room 226
Montreal
H3A 2A7
Canada

Sponsor information

Montreal Inter-University Group for Nursing Research (GRISIM) (Canada)
Research organisation

3875, rue St-Urbain
Bureau 205
Montreal
H2W 1V1
Canada

Website http://www.grisim.ca/index.php?L=1

Funders

Funder type

Research organisation

Quebec Health Research Fund (Fonds de recherche en Santé du Québec [FRSQ])/Montreal Inter-University Group for Nursing Research (Groupe de Recherche Interuniversitaire en Sciences Infirmières de Montréal [GRISIM]) (Canada)

No information available

Canadian Nurses Foundation (Canadian Nurses Fondation [CNF]) (Canada)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article 01/11/2012 19/07/2021 Yes No

Editorial Notes

19/07/2021: Publication reference and total final enrolment added.